nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—KIT—myenteric nerve plexus—jejunal cancer	0.0546	0.0546	CbGeAlD
Dasatinib—WEE2—lymphoid tissue—jejunal cancer	0.0257	0.0257	CbGeAlD
Dasatinib—WEE2—endocrine gland—jejunal cancer	0.021	0.021	CbGeAlD
Dasatinib—TEC—lymphoid tissue—jejunal cancer	0.0195	0.0195	CbGeAlD
Dasatinib—TEC—endocrine gland—jejunal cancer	0.0159	0.0159	CbGeAlD
Dasatinib—STAT5B—pancreas—jejunal cancer	0.0132	0.0132	CbGeAlD
Dasatinib—FRK—lymphoid tissue—jejunal cancer	0.0132	0.0132	CbGeAlD
Dasatinib—BLK—lymphoid tissue—jejunal cancer	0.0127	0.0127	CbGeAlD
Dasatinib—EPHB2—lymphoid tissue—jejunal cancer	0.0126	0.0126	CbGeAlD
Dasatinib—TXK—lymphoid tissue—jejunal cancer	0.0122	0.0122	CbGeAlD
Dasatinib—STAT5B—lymphoid tissue—jejunal cancer	0.0114	0.0114	CbGeAlD
Dasatinib—SIK2—endocrine gland—jejunal cancer	0.011	0.011	CbGeAlD
Dasatinib—TEC—lymph node—jejunal cancer	0.011	0.011	CbGeAlD
Dasatinib—FRK—endocrine gland—jejunal cancer	0.0107	0.0107	CbGeAlD
Dasatinib—PKMYT1—endocrine gland—jejunal cancer	0.0107	0.0107	CbGeAlD
Dasatinib—BMX—endocrine gland—jejunal cancer	0.0105	0.0105	CbGeAlD
Dasatinib—TXK—endocrine gland—jejunal cancer	0.00992	0.00992	CbGeAlD
Dasatinib—PTK6—endocrine gland—jejunal cancer	0.00982	0.00982	CbGeAlD
Dasatinib—CSK—smooth muscle tissue—jejunal cancer	0.00964	0.00964	CbGeAlD
Dasatinib—ZAK—lymphoid tissue—jejunal cancer	0.00951	0.00951	CbGeAlD
Dasatinib—STAT5B—endocrine gland—jejunal cancer	0.00929	0.00929	CbGeAlD
Dasatinib—LYN—lymphoid tissue—jejunal cancer	0.00926	0.00926	CbGeAlD
Dasatinib—BTK—lymphoid tissue—jejunal cancer	0.00907	0.00907	CbGeAlD
Dasatinib—STK35—pancreas—jejunal cancer	0.00897	0.00897	CbGeAlD
Dasatinib—CSK—pancreas—jejunal cancer	0.00891	0.00891	CbGeAlD
Dasatinib—EPHB1—lymph node—jejunal cancer	0.00862	0.00862	CbGeAlD
Dasatinib—SIK3—endocrine gland—jejunal cancer	0.00835	0.00835	CbGeAlD
Dasatinib—SIK1—pancreas—jejunal cancer	0.00807	0.00807	CbGeAlD
Dasatinib—LIMK2—lymphoid tissue—jejunal cancer	0.008	0.008	CbGeAlD
Dasatinib—MAPK14—smooth muscle tissue—jejunal cancer	0.00797	0.00797	CbGeAlD
Dasatinib—ERBB3—pancreas—jejunal cancer	0.00791	0.00791	CbGeAlD
Dasatinib—ZAK—endocrine gland—jejunal cancer	0.00776	0.00776	CbGeAlD
Dasatinib—CSK—lymphoid tissue—jejunal cancer	0.0077	0.0077	CbGeAlD
Dasatinib—HCK—lymphoid tissue—jejunal cancer	0.0076	0.0076	CbGeAlD
Dasatinib—EPHA5—endocrine gland—jejunal cancer	0.0076	0.0076	CbGeAlD
Dasatinib—LYN—endocrine gland—jejunal cancer	0.00756	0.00756	CbGeAlD
Dasatinib—EPHB4—smooth muscle tissue—jejunal cancer	0.00756	0.00756	CbGeAlD
Dasatinib—JAK2—smooth muscle tissue—jejunal cancer	0.0075	0.0075	CbGeAlD
Dasatinib—BMPR1B—endocrine gland—jejunal cancer	0.00744	0.00744	CbGeAlD
Dasatinib—FYN—smooth muscle tissue—jejunal cancer	0.0074	0.0074	CbGeAlD
Dasatinib—TNK2—endocrine gland—jejunal cancer	0.0073	0.0073	CbGeAlD
Dasatinib—BMX—lymph node—jejunal cancer	0.00724	0.00724	CbGeAlD
Dasatinib—MAP4K5—smooth muscle tissue—jejunal cancer	0.00723	0.00723	CbGeAlD
Dasatinib—BLK—lymph node—jejunal cancer	0.00716	0.00716	CbGeAlD
Dasatinib—EPHB4—pancreas—jejunal cancer	0.00699	0.00699	CbGeAlD
Dasatinib—SIK1—lymphoid tissue—jejunal cancer	0.00698	0.00698	CbGeAlD
Dasatinib—TESK1—endocrine gland—jejunal cancer	0.00686	0.00686	CbGeAlD
Dasatinib—TXK—lymph node—jejunal cancer	0.00686	0.00686	CbGeAlD
Dasatinib—EPHA2—pancreas—jejunal cancer	0.00685	0.00685	CbGeAlD
Dasatinib—ERBB3—lymphoid tissue—jejunal cancer	0.00684	0.00684	CbGeAlD
Dasatinib—MAP3K2—lymphoid tissue—jejunal cancer	0.00678	0.00678	CbGeAlD
Dasatinib—STK36—endocrine gland—jejunal cancer	0.00675	0.00675	CbGeAlD
Dasatinib—MAP4K5—pancreas—jejunal cancer	0.00669	0.00669	CbGeAlD
Dasatinib—YES1—smooth muscle tissue—jejunal cancer	0.00668	0.00668	CbGeAlD
Dasatinib—PDGFRA—smooth muscle tissue—jejunal cancer	0.00655	0.00655	CbGeAlD
Dasatinib—LIMK2—endocrine gland—jejunal cancer	0.00653	0.00653	CbGeAlD
Dasatinib—SRC—smooth muscle tissue—jejunal cancer	0.00643	0.00643	CbGeAlD
Dasatinib—STAT5B—lymph node—jejunal cancer	0.00642	0.00642	CbGeAlD
Dasatinib—MAPK14—lymphoid tissue—jejunal cancer	0.00637	0.00637	CbGeAlD
Dasatinib—FGR—lymphoid tissue—jejunal cancer	0.00635	0.00635	CbGeAlD
Dasatinib—STK35—endocrine gland—jejunal cancer	0.00633	0.00633	CbGeAlD
Dasatinib—CSK—endocrine gland—jejunal cancer	0.00629	0.00629	CbGeAlD
Dasatinib—HCK—endocrine gland—jejunal cancer	0.00621	0.00621	CbGeAlD
Dasatinib—YES1—pancreas—jejunal cancer	0.00618	0.00618	CbGeAlD
Dasatinib—JAK2—lymphoid tissue—jejunal cancer	0.006	0.006	CbGeAlD
Dasatinib—SRC—pancreas—jejunal cancer	0.00594	0.00594	CbGeAlD
Dasatinib—EPHA3—lymph node—jejunal cancer	0.00593	0.00593	CbGeAlD
Dasatinib—EPHA2—lymphoid tissue—jejunal cancer	0.00593	0.00593	CbGeAlD
Dasatinib—FYN—lymphoid tissue—jejunal cancer	0.00592	0.00592	CbGeAlD
Dasatinib—RIPK2—endocrine gland—jejunal cancer	0.00584	0.00584	CbGeAlD
Dasatinib—MAP4K5—lymphoid tissue—jejunal cancer	0.00578	0.00578	CbGeAlD
Dasatinib—SIK3—lymph node—jejunal cancer	0.00577	0.00577	CbGeAlD
Dasatinib—CSF1R—smooth muscle tissue—jejunal cancer	0.00577	0.00577	CbGeAlD
Dasatinib—SIK1—endocrine gland—jejunal cancer	0.0057	0.0057	CbGeAlD
Dasatinib—EPHA4—endocrine gland—jejunal cancer	0.00564	0.00564	CbGeAlD
Dasatinib—ERBB3—endocrine gland—jejunal cancer	0.00559	0.00559	CbGeAlD
Dasatinib—MAP3K2—endocrine gland—jejunal cancer	0.00553	0.00553	CbGeAlD
Dasatinib—ZAK—lymph node—jejunal cancer	0.00537	0.00537	CbGeAlD
Dasatinib—YES1—lymphoid tissue—jejunal cancer	0.00534	0.00534	CbGeAlD
Dasatinib—KIT—smooth muscle tissue—jejunal cancer	0.00524	0.00524	CbGeAlD
Dasatinib—PDGFRA—lymphoid tissue—jejunal cancer	0.00524	0.00524	CbGeAlD
Dasatinib—MAPK14—endocrine gland—jejunal cancer	0.0052	0.0052	CbGeAlD
Dasatinib—FGR—endocrine gland—jejunal cancer	0.00518	0.00518	CbGeAlD
Dasatinib—BMPR1B—lymph node—jejunal cancer	0.00515	0.00515	CbGeAlD
Dasatinib—SRC—lymphoid tissue—jejunal cancer	0.00514	0.00514	CbGeAlD
Dasatinib—BTK—lymph node—jejunal cancer	0.00512	0.00512	CbGeAlD
Dasatinib—PDGFRB—smooth muscle tissue—jejunal cancer	0.00512	0.00512	CbGeAlD
Dasatinib—TNK2—lymph node—jejunal cancer	0.00505	0.00505	CbGeAlD
Dasatinib—FMO3—endocrine gland—jejunal cancer	0.005	0.005	CbGeAlD
Dasatinib—EPHB4—endocrine gland—jejunal cancer	0.00493	0.00493	CbGeAlD
Dasatinib—JAK2—endocrine gland—jejunal cancer	0.0049	0.0049	CbGeAlD
Dasatinib—KIT—pancreas—jejunal cancer	0.00484	0.00484	CbGeAlD
Dasatinib—EPHA2—endocrine gland—jejunal cancer	0.00484	0.00484	CbGeAlD
Dasatinib—FYN—endocrine gland—jejunal cancer	0.00483	0.00483	CbGeAlD
Dasatinib—TESK1—lymph node—jejunal cancer	0.00474	0.00474	CbGeAlD
Dasatinib—PDGFRB—pancreas—jejunal cancer	0.00473	0.00473	CbGeAlD
Dasatinib—MAP3K3—endocrine gland—jejunal cancer	0.00472	0.00472	CbGeAlD
Dasatinib—MAP4K5—endocrine gland—jejunal cancer	0.00472	0.00472	CbGeAlD
Dasatinib—EPHB3—lymph node—jejunal cancer	0.00467	0.00467	CbGeAlD
Dasatinib—STK36—lymph node—jejunal cancer	0.00467	0.00467	CbGeAlD
Dasatinib—CSF1R—lymphoid tissue—jejunal cancer	0.00461	0.00461	CbGeAlD
Dasatinib—ABL1—smooth muscle tissue—jejunal cancer	0.00456	0.00456	CbGeAlD
Dasatinib—LIMK2—lymph node—jejunal cancer	0.00451	0.00451	CbGeAlD
Dasatinib—STK35—lymph node—jejunal cancer	0.00437	0.00437	CbGeAlD
Dasatinib—YES1—endocrine gland—jejunal cancer	0.00436	0.00436	CbGeAlD
Dasatinib—CSK—lymph node—jejunal cancer	0.00435	0.00435	CbGeAlD
Dasatinib—HCK—lymph node—jejunal cancer	0.00429	0.00429	CbGeAlD
Dasatinib—PDGFRA—endocrine gland—jejunal cancer	0.00427	0.00427	CbGeAlD
Dasatinib—ABL2—lymph node—jejunal cancer	0.00426	0.00426	CbGeAlD
Dasatinib—ABL1—pancreas—jejunal cancer	0.00422	0.00422	CbGeAlD
Dasatinib—SRC—endocrine gland—jejunal cancer	0.00419	0.00419	CbGeAlD
Dasatinib—KIT—lymphoid tissue—jejunal cancer	0.00419	0.00419	CbGeAlD
Dasatinib—PDGFRB—lymphoid tissue—jejunal cancer	0.00409	0.00409	CbGeAlD
Dasatinib—RIPK2—lymph node—jejunal cancer	0.00403	0.00403	CbGeAlD
Dasatinib—SIK1—lymph node—jejunal cancer	0.00394	0.00394	CbGeAlD
Dasatinib—EPHA4—lymph node—jejunal cancer	0.0039	0.0039	CbGeAlD
Dasatinib—CYP1B1—smooth muscle tissue—jejunal cancer	0.00386	0.00386	CbGeAlD
Dasatinib—ERBB3—lymph node—jejunal cancer	0.00386	0.00386	CbGeAlD
Dasatinib—MAP2K5—endocrine gland—jejunal cancer	0.00386	0.00386	CbGeAlD
Dasatinib—MAP3K2—lymph node—jejunal cancer	0.00382	0.00382	CbGeAlD
Dasatinib—CSF1R—endocrine gland—jejunal cancer	0.00376	0.00376	CbGeAlD
Dasatinib—ABL1—lymphoid tissue—jejunal cancer	0.00364	0.00364	CbGeAlD
Dasatinib—MAPK14—lymph node—jejunal cancer	0.0036	0.0036	CbGeAlD
Dasatinib—FGR—lymph node—jejunal cancer	0.00358	0.00358	CbGeAlD
Dasatinib—LCK—lymph node—jejunal cancer	0.00358	0.00358	CbGeAlD
Dasatinib—FMO3—lymph node—jejunal cancer	0.00346	0.00346	CbGeAlD
Dasatinib—KIT—endocrine gland—jejunal cancer	0.00342	0.00342	CbGeAlD
Dasatinib—EPHB4—lymph node—jejunal cancer	0.00341	0.00341	CbGeAlD
Dasatinib—JAK2—lymph node—jejunal cancer	0.00338	0.00338	CbGeAlD
Dasatinib—EPHA2—lymph node—jejunal cancer	0.00334	0.00334	CbGeAlD
Dasatinib—PDGFRB—endocrine gland—jejunal cancer	0.00334	0.00334	CbGeAlD
Dasatinib—FYN—lymph node—jejunal cancer	0.00334	0.00334	CbGeAlD
Dasatinib—MAP4K5—lymph node—jejunal cancer	0.00326	0.00326	CbGeAlD
Dasatinib—MAP3K3—lymph node—jejunal cancer	0.00326	0.00326	CbGeAlD
Dasatinib—EPHB6—lymph node—jejunal cancer	0.00312	0.00312	CbGeAlD
Dasatinib—CYP1B1—lymphoid tissue—jejunal cancer	0.00309	0.00309	CbGeAlD
Dasatinib—YES1—lymph node—jejunal cancer	0.00301	0.00301	CbGeAlD
Dasatinib—ABL1—endocrine gland—jejunal cancer	0.00298	0.00298	CbGeAlD
Dasatinib—PDGFRA—lymph node—jejunal cancer	0.00296	0.00296	CbGeAlD
Dasatinib—SRC—lymph node—jejunal cancer	0.0029	0.0029	CbGeAlD
Dasatinib—MAP2K5—lymph node—jejunal cancer	0.00267	0.00267	CbGeAlD
Dasatinib—CSF1R—lymph node—jejunal cancer	0.0026	0.0026	CbGeAlD
Dasatinib—CYP1B1—endocrine gland—jejunal cancer	0.00252	0.00252	CbGeAlD
Dasatinib—CYP3A5—pancreas—jejunal cancer	0.00247	0.00247	CbGeAlD
Dasatinib—KIT—lymph node—jejunal cancer	0.00236	0.00236	CbGeAlD
Dasatinib—PDGFRB—lymph node—jejunal cancer	0.00231	0.00231	CbGeAlD
Dasatinib—ABL1—lymph node—jejunal cancer	0.00206	0.00206	CbGeAlD
Dasatinib—CYP1A2—endocrine gland—jejunal cancer	0.00181	0.00181	CbGeAlD
Dasatinib—CYP1A1—endocrine gland—jejunal cancer	0.00178	0.00178	CbGeAlD
Dasatinib—CYP1B1—lymph node—jejunal cancer	0.00174	0.00174	CbGeAlD
Dasatinib—CYP3A5—endocrine gland—jejunal cancer	0.00174	0.00174	CbGeAlD
Dasatinib—ABCB1—pancreas—jejunal cancer	0.00131	0.00131	CbGeAlD
Dasatinib—CYP3A4—endocrine gland—jejunal cancer	0.00131	0.00131	CbGeAlD
Dasatinib—ABCG2—lymph node—jejunal cancer	0.0013	0.0013	CbGeAlD
Dasatinib—CYP1A1—lymph node—jejunal cancer	0.00123	0.00123	CbGeAlD
Dasatinib—ABCB1—lymphoid tissue—jejunal cancer	0.00113	0.00113	CbGeAlD
Dasatinib—ABCB1—endocrine gland—jejunal cancer	0.000925	0.000925	CbGeAlD
Dasatinib—ABCB1—lymph node—jejunal cancer	0.00064	0.00064	CbGeAlD
